Alamar Biosciences (ALMR) COO receives RSUs, major option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Alamar Biosciences Chief Operating Officer Shiping Chen reported equity compensation grants and pre‑IPO share conversions, with no open‑market buying or selling. Chen received 37,220 shares of Common Stock as restricted stock units that vest monthly, bringing direct Common Stock holdings to 760,105 shares after the award.
The filing also shows automatic conversions of Class A Common Stock, Founders Preferred Stock, Series A‑1 Preferred Stock and Class B Common Stock into Common Stock immediately before Alamar’s IPO, plus administrative reclassifications of related stock options. Chen was granted a new stock option over 163,358 shares at $17.00 per share, alongside existing options with lower exercise prices.
Positive
- None.
Negative
- None.
Insider Trade Summary
496,671 shares exercised/converted
Mixed
13 txns
Insider
Chen Shiping
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class A Common Stock | 247,311 | $0.00 | -- |
| Conversion | Founders Preferred Stock | 73,200 | $0.00 | -- |
| Conversion | Series A-1 Preferred Stock | 176,160 | $0.00 | -- |
| Other | Stock Option (Right to Buy) | 300,883 | $0.00 | -- |
| Other | Stock Option (Right to Buy) | 300,883 | $0.00 | -- |
| Other | Stock Option (Right to Buy) | 12,190 | $0.00 | -- |
| Other | Stock Option (Right to Buy) | 12,190 | $0.00 | -- |
| Conversion | Class B Common Stock | 320,511 | $0.00 | -- |
| Conversion | Class B Common Stock | 72,853 | $0.00 | -- |
| Other | Class B Common Stock | 722,885 | $0.00 | -- |
| Other | Common Stock | 722,885 | $0.00 | -- |
| Grant/Award | Common Stock | 37,220 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 163,358 | $0.00 | -- |
Holdings After Transaction:
Class A Common Stock — 0 shares (Direct, null);
Founders Preferred Stock — 0 shares (Direct, null);
Series A-1 Preferred Stock — 0 shares (Direct, null);
Stock Option (Right to Buy) — 0 shares (Direct, null);
Class B Common Stock — 650,032 shares (Direct, null);
Common Stock — 722,885 shares (Direct, null)
Footnotes (1)
- The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the "IPO"). The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO. Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO. Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date. Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date. The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date.
Key Figures
RSU grant: 37,220 shares
Common Stock holdings: 760,105 shares
New option grant: 163,358 shares at $17.00
+5 more
8 metrics
RSU grant
37,220 shares
Common Stock RSUs vesting monthly from April 20, 2026
Common Stock holdings
760,105 shares
Direct Common Stock owned after RSU grant
New option grant
163,358 shares at $17.00
Stock option expiring April 15, 2036
Existing option
300,883 shares at $3.34
Stock option expiring January 15, 2035
Existing option
12,190 shares at $7.60
Stock option expiring January 14, 2036
Converted Series A-1 Preferred
176,160 shares
Converted into 72,853 Class B Common shares before IPO
Converted Founders Preferred
73,200 shares
Converted into 73,200 Class B Common shares before IPO
Converted Class A Common
247,311 shares
Converted into 247,311 Class B Common shares before IPO
Key Terms
restricted stock units ("RSUs"), Class B Common Stock, Series A-1 Preferred Stock, Founders Preferred Stock, +2 more
6 terms
restricted stock units ("RSUs") financial
"Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Class B Common Stock financial
"Each share of Class B Common Stock was reclassified into one share"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Series A-1 Preferred Stock financial
"The Series A-1 Preferred Stock is convertible into shares of Class B"
Series A-1 preferred stock is a specific class of company shares created in an early financing round that typically gives its holders priority over common shareholders for dividends and money if the company is sold or liquidates. Think of it as a special ticket with upfront privileges — often convertible into ordinary shares and sometimes carrying voting or protective rights — so investors use it to reduce risk and preserve control compared with ordinary stock.
Founders Preferred Stock financial
"The Class A Common Stock and Founders Preferred Stock automatically converted"
initial public offering financial
"immediately prior to the completion of the initial public offering of the Issuer's Common Stock"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
stock option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 17.0000"
FAQ
What did Alamar Biosciences (ALMR) COO Shiping Chen report in this Form 4?
Shiping Chen reported equity compensation and share conversions, not market trades. The filing includes a 37,220-share restricted stock unit grant and a 163,358-share stock option grant, plus automatic conversions of various preferred and Class B shares into Common Stock ahead of Alamar’s IPO.
What restricted stock units were granted to Alamar Biosciences (ALMR) COO Shiping Chen?
Chen received 37,220 shares of Common Stock in the form of restricted stock units. These RSUs vest monthly from the grant date, contingent on Chen’s continuous service with Alamar Biosciences at each vesting date, aligning compensation with ongoing employment over time.
What new stock option did the Alamar Biosciences (ALMR) COO receive?
Chen was granted a stock option for 163,358 shares of Common Stock at an exercise price of $17.00 per share. Twenty-five percent of these shares vest on April 16, 2027, with the remainder vesting monthly thereafter, subject to continued service, and expiring in 2036.